North America 3D Bioprinting Market (2025-2031) | Revenue, Industry, Trends, Share, Analysis, Outlook, Value, Forecast, Growth, Size & Companies

Market Forecast By Material Types (Living Cells, Hydrogels, Extracellular Matrices, and Others), By Technologies (Micro Extrusion Bioprinting, Magnetic Levitation, Inkjet-Based, Syringe-Based, Laser-Based and Others), By Components (3D Bioprinters, Biomaterials, and Scaffolds), By Applications ((Research Application (3D Cell Culture, Regenerative Medicine, Drug Testing and Others), Clinical Application (Dental, Orthopedic, Skin Substitutes, and Grafts and Vascular Tissues and Organs)), By End Users (Pharmaceutical & Biotechnology Companies, Research Organizations & Academic Institutes, and Others), By Countries (the US, Canada and Rest of North America) and Competitive Landscape

Product Code: ETC000712 Publication Date: Aug 2019 Product Type: Report
Publisher: 6Wresearch No. of Pages: 200 No. of Figures: 90 No. of Tables: 30

North America 3D Bioprinting Market Highlights

Report Name North America 3D Bioprinting Market
Forecast period 2025-2031
CAGR 20.3%
Growing Sector Healthcare

Topics Covered in the North America 3D Bioprinting Market Report

The North America 3D Bioprinting Market report extensively covers the market by Material Types, Technologies, Components, Applications, End Users, and Countries. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers that would help the stakeholders devise and align their market strategies according to the current and future market dynamics.

North America 3D Bioprinting Market Synopsis

The North America 3D Bioprinting Market is set to witness significant growth during the forecast period. The market growth can be attributed to the increasing demand for replacement organs and tissues, advancements in bioprinting technologies, rising investments in research and development activities, and growing applications of bioprinted products in the healthcare sector.

According to 6Wresearch, The North America 3D Bioprinting Market is projected to grow at a CAGR of 20.3% during the forecast period. The primary growth driver for the North America 3D Bioprinting Market is the increasing demand for advanced healthcare solutions. With a growing ageing population and rising prevalence of diseases, there is a significant need for replacement organs and tissues. This has led to a surge in demand for bioprinted products, as they offer personalized and more effective treatment options.Moreover, advancements in bioprinting technologies have also contributed to market growth. The development of new materials, such as bioinks and living cells, has made it possible to create more complex and functional structures.  Additionally, investments in research and development activities by key players and government organizations have further propelled the market growth.

Despite the positive growth prospects, the North America 3D Bioprinting market also faces some challenges. One of the major challenges is the strict regulations and approvals required for the use of certain types of biomaterials. This can lead to delays in product launches and hinder overall market growth. Additionally, there is a lack of skilled professionals in this field, which can act as a barrier to market expansion. Moreover, the high cost associated with the 3D bioprinting process can also pose challenges for manufacturers in this market.

North America 3D Bioprinting Market: Leading Players

Prominent players operating in the North America 3D Bioprinting Market include Organovo, CELLINK, Cyfuse Biomedical, Aspect Biosystems, and Regenovo Biotechnology. These companies focus on strategies such as partnerships, mergers and acquisitions, and product developments to strengthen their market position. Currently, Organovo holds the dominant share in the market.

North America 3D Bioprinting Market: Government Regulations

The North America 3D Bioprinting Market is subject to government regulations and approvals for the use of certain materials and products in medical applications. Organizations such as the Food and Drug Administration (FDA) in the United States and Health Canada have set guidelines for product approvals, safety, and efficacy. These regulations ensure that bioprinted products meet quality standards and are safe for use in medical treatments.

Future Insights of the Market

North America 3D Bioprinting Market is expected to continue its growth trajectory in the coming years. The advancements in bioprinting technologies are expected to drive market growth, with a focus on creating more complex and functional structures for medical applications. Moreover, the rising investments in research and development activities will lead to further innovations in bioprinting materials, processes, and applications. This could open up new opportunities for market players and expand the scope of 3D bioprinting in healthcare.

Market Segmentation by Material Types

According to Dhaval, Research Manager, 6Wresearch, the living cells segment holds the largest market share as they play a crucial role in creating functional and viable organs.

Market Segmentation by Technologies

The micro extrusion bioprinting technology holds the dominant share in the North America 3D Bioprinting Market due to its wide range of applications and ease of use.

Market Segmentation by Components

3D Bioprinters hold the largest market share in the North America 3D Bioprinting Market, attributing to their significant role in the printing process.

Market Segmentation by Applications

The research applications hold the largest market share in the North America 3D Bioprinting Market, driven by an increasing preference for 3D bioprinting in drug research and testing.

Market Segmentation by End Users

The pharmaceutical & biotechnology companies segment holds the largest market share in the North America 3D Bioprinting Market. This can be attributed to the increasing demand for advanced 3D bioprinting solutions in these sectors for various applications such as drug development and personalized medicine.

Market Segmentation by Country

US holds the largest share in the North America 3D Bioprinting Market. This can be attributed to the presence of major pharmaceutical and biotechnology companies, research organizations, and academic institutes in the country.

Key Attractiveness of the Report

  • 10 Years of Market Numbers.
  • Historical Data Starting from 2021 to 2024.
  • Base Year: 2024
  • Forecast Data until 2031.
  • Key Performance Indicators Impacting the market.
  • Major Upcoming Developments and Projects.

Key Highlights of the Report:

  • North America 3D Bioprinting Market Overview
  • North America 3D Bioprinting Market Outlook
  • North America 3D Bioprinting Market Forecast
  • Historical Data of North America 3D Bioprinting Market Revenues for the Period 2021-2031
  • North America 3D Bioprinting Market Size and North America 3D Bioprinting Market Forecast of Revenues, Until 2031
  • Historical Data of North America 3D Bioprinting Market Revenues, By Material Type, for the Period 2021-2031
  • Market Size & Forecast of North America 3D Bioprinting Market Revenues, By Material Type, Until 2031
  • Historical Data of North America 3D Bioprinting Market Revenues, By Technology, for the Period 2021-2031
  • Market Size & Forecast of North America 3D Bioprinting Market Revenues, By Technology, Until 2031
  • Historical Data of North America 3D Bioprinting Market Revenues, By Component, for the Period 2021-2031
  • Market Size & Forecast of North America 3D Bioprinting Market Revenues, By Component, Until 2031
  • Historical Data of North America 3D Bioprinting Market Revenues, By Applications, for the Period 2021-2031
  • Market Size & Forecast of North America 3D Bioprinting Market Revenues, By Applications, Until 2031
  • Historical Data of North America 3D Bioprinting Market Revenues, By End User, for the Period 2021-2031
  • Market Size & Forecast of North America 3D Bioprinting Market Revenues, By End User, Until 2031
  • Historical Data of US 3D Bioprinting Market Revenues, for the Period 2021-2031
  • Market Size & Forecast of US 3D Bioprinting Market Revenues, Until 2031
  • Historical Data of Canada 3D Bioprinting Market Revenues, for the Period 2021-2031
  • Market Size & Forecast of Canada 3D Bioprinting Market Revenues, Until 2031
  • Market Drivers and Restraints
  • North America 3D Bioprinting Market Price Trends
  • North America 3D Bioprinting Market Trends and Industry Life Cycle
  • Porter’s Five Force Analysis
  • Market Opportunity Assessment
  • North America 3D Bioprinting Market Share, By Material Type, By Players
  • North America 3D Bioprinting Market Overview on Competitive Benchmarking
  • Company Profiles
  • Key Strategic Recommendations

Market Segmentation

The market study offers an exhaustive analysis of the following market segments:

By Material Types

  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Others

By Technologies

  • Micro Extrusion Bioprinting
  • Magnetic Levitation
  • Inkjet-Based
  • Syringe-Based
  • Laser-Based
  • Others

By Components

  • 3D Bioprinters
  • Biomaterials
  • Scaffolds

By Applications

  • Research Application (3D Cell Culture, Regenerative Medicine, Drug Testing And Others)
  • Clinical Application (Dental, Orthopedic, Skin Substitutes, And Grafts And Vascular Tissues And Organs)

By End Users

  • Pharmaceutical & Biotechnology Companies
  • Research Organizations & Academic Institutes
  • Others

By Countries

  • US
  • Canada
  • Rest Of North America
North America 3D Bioprinting Market (2025-2031): FAQs
The growth is driven by advancements in medical technology, a growing demand for organ transplants, and supportive government initiatives for healthcare innovation.
3D bioprinting enables the creation of customized tissues and organs, which can aid in drug research, reduce organ donor shortages, and improve patient-specific treatment outcomes.
Alongside healthcare, industries such as cosmetics and biotechnology are leveraging 3D bioprinting for testing and research purposes, further bolstering market expansion.
Continuous investment in research and development is leading to innovative bioprinting technologies and materials, ensuring ongoing improvements and wider adoption in various applications.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary
2 Introduction
    2.1 Report Description
    2.2 Key Highlights of The Report
    2.3 Market Scope & Segmentation
    2.4 Research Methodology
    2.5 Assumptions
3 North America 3D Bioprinting Market Overview
    3.1 North America 3D Bioprinting Market Revenues, 2021-2031F
    3.2 North America 3D Bioprinting Market Revenue Share, By Material Type, 2021 & 2031F
    3.3 North America 3D Bioprinting Market Revenue Share, By Technology, 2021 & 2031F
    3.4 North America 3D Bioprinting Market Revenue Share, By Component, 2021 & 2031F
    3.5 North America 3D Bioprinting Market Revenue Share, By Application, 2021 & 2031F
    3.6 North America 3D Bioprinting Market Revenue Share, By End User, 2021 & 2031F
    3.7 North America 3D Bioprinting Market Revenue Share, By Regions, 2021 & 2031F
    3.8 North America 3D Bioprinting Market Industry Life Cycle
    3.9 North America 3D Bioprinting Market- Porter's Five Forces, 2024
4 North America 3D Bioprinting Market Dynamics
    4.1 Impact Analysis
    4.2 Market Drivers
    4.3 Market Restraints
5 North America 3D Bioprinting Market Trends
6 North America 3D Bioprinting Market Overview, By Material Types
    6.1 North America 3D Bioprinting Market Revenues, By Living Cells, 2021-2031F
    6.2 North America 3D Bioprinting Market Revenues, By Hydrogels, 2021-2031F
    6.3 North America 3D Bioprinting Market Revenues, By Extracellular Matrices, 2021-2031F
    6.4 North America 3D Bioprinting Market Revenues, By Others, 2021-2031F
7 North America 3D Bioprinting Market Overview, By Technologies
    7.1 North America 3D Bioprinting Market Revenues, By Micro Extrusion Bioprinting, 2021-2031F
    7.2 North America 3D Bioprinting Market Revenues, By Magnetic Levitation, 2021-2031F
    7.3 North America 3D Bioprinting Market Revenues, By Inkjet-based, 2021-2031F
    7.4 North America 3D Bioprinting Market Revenues, By Syringe-based, 2021-2031F
    7.5 North America 3D Bioprinting Market Revenues, By Laser-based, 2021-2031F
    7.6 North America 3D Bioprinting Market Revenues, By Others, 2021-2031F
8 North America 3D Bioprinting Market Overview, By Components
    8.1 North America 3D Bioprinting Market Revenues, By 3D Bioprinters, 2021-2031F
    8.2 North America 3D Bioprinting Market Revenues, By Biomaterials, 2021-2031F
    8.3 North America 3D Bioprinting Market Revenues, By Scaffolds, 2021-2031F
9 North America 3D Bioprinting Market Overview, By Applications
    9.1 North America 3D Bioprinting Market Revenues, By Research Application, 2021-2031F
          9.1.1 North America 3D Bioprinting Market Revenues, By 3D Cell Culture, 2021-2031F
          9.1.2 North America 3D Bioprinting Market Revenues, By Regenerative Medicine, 2021-2031F
          9.1.3 North America 3D Bioprinting Market Revenues, By Drug Testing, 2021-2031F
          9.1.4 North America 3D Bioprinting Market Revenues, By Others, 2021-2031F
    9.2 North America 3D Bioprinting Market Revenues, By Clinical Application, 2021-2031F
          9.2.1 North America 3D Bioprinting Market Revenues, By Dental, 2021-2031F
          9.2.2 North America 3D Bioprinting Market Revenues, By Orthopedic, 2021-2031F
          9.2.3 North America 3D Bioprinting Market Revenues, By Skin Substitutes and Grafts, 2021-2031F
          9.2.4 North America 3D Bioprinting Market Revenues, By Vascular Tissues and Organs, 2021-2031F
10 North America 3D Bioprinting Market Overview, By End Users
      10.1 North America 3D Bioprinting Market Revenues, By Pharmaceutical & Biotechnology Companies, 2021-2031F
      10.2 North America 3D Bioprinting Market Revenues, By Research Organizations & Academic Institutes,
              2021-2031F
      10.3 North America 3D Bioprinting Market Revenues, By Others, 2021-2031F
11 US 3D Bioprinting Market Overview
      11.1 US 3D Bioprinting Market Revenues, 2021-2031F
      11.2 US 3D Bioprinting Market Revenues, By Material Type, 2021-2031F
      11.3 US 3D Bioprinting Market Revenues, By Technology, 2021-2031F
      11.4 US 3D Bioprinting Market Revenues, By Component, 2021-2031F
      11.5 US 3D Bioprinting Market Revenues, By Application, 2021-2031F
      11.6 US 3D Bioprinting Market Revenues, By End User, 2021-2031F
12 Canada 3D Bioprinting Market Overview
      12.1 Canada 3D Bioprinting Market Revenues, 2021-2031F
      12.2 Canada 3D Bioprinting Market Revenues, By Material Type, 2021-2031F
      12.3 Canada 3D Bioprinting Market Revenues, By Technology, 2021-2031F
      12.4 Canada 3D Bioprinting Market Revenues, By Component, 2021-2031F
      12.5 Canada 3D Bioprinting Market Revenues, By Application, 2021-2031F
      12.6 Canada 3D Bioprinting Market Revenues, By End User, 2021-2031F
13 Rest of North America 3D Bioprinting Market Overview
      13.1 Rest of North America 3D Bioprinting Market Revenues, 2021-2031F
14 North America 3D Bioprinting Market Opportunity Assessment,
      14.1 North America 3D Bioprinting Market Opportunity Assessment, By Material Type, 2031F
      14.2 North America 3D Bioprinting Market Opportunity Assessment, By Technology, 2031F
      14.3 North America 3D Bioprinting Market Opportunity Assessment, By Component, 2031F
      14.4 North America 3D Bioprinting Market Opportunity Assessment, By Application, 2031F
      14.5 North America 3D Bioprinting Market Opportunity Assessment, By End User, 2031F
15 North America 3D Bioprinting Market Competitive Landscape
      15.1 North America 3D Bioprinting Market Revenue Share, By Companies, 2024
              15.1.1 US 3D Bioprinting Market Revenue Share, By Companies, 2024
              15.1.2 Canada 3D Bioprinting Market Revenue Share, By Companies, 2024
      15.2 North America 3D Bioprinting Market Competitive Benchmarking, By Operating Parameters
16 Company Profiles
17 Strategic Recommendations
18 Disclaimer
Pricing
  • Single User License
    $ 4,560
  • Department License
    $ 5,055
  • Site License
    $ 5,595
  • Global License
    $ 6,000
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All